Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alzchem Group AGCHIX:ACTD 50 Equity-to-Asset is 0.42 as of Mar. 2026, which is 68% above its 10-year median of 0.25. GuruFocus rates CHIX:ACTD with a GF Score™ of 50/100. The stock has 4 warning signs investors should review. Among 1,612 Chemicals companies, Alzchem Group AG ranks worse than 76.24% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Alzchem Group AG's Total Stockholders Equity for the quarter that ended in Mar. 2026 was €274.1 Mil. Alzchem Group AG's Total Assets for the quarter that ended in Mar. 2026 was €654.5 Mil.
Therefore, Alzchem Group AG's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.42.
The historical rank and industry rank for Alzchem Group AG's Equity-to-Asset or its related term are showing as below:
CHIX:ACTd'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.16 Med: 0.25 Max: 0.43
Current: 0.42
During the past 13 years, the highest Equity to Asset Ratio of Alzchem Group AG was 0.43. The lowest was 0.16. And the median was 0.25.
CHIX:ACTd's Equity-to-Asset is ranked worse than 76.24% of 1612
companies
in the Chemicals industry
Industry Median: 0.6
vs CHIX:ACTd: 0.42
Alzchem Group AG (CHIX:ACTd) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Alzchem Group AG Equity-to-Asset Related Terms
Alzchem Group AG Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Alzchem Group AG's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:ACTD vs LIN, SHW, ECL: Equity-to-Asset Comparison
For the Specialty Chemicals subindustry, Alzchem Group AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alzchem Group AG Equity-to-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Alzchem Group AG's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Alzchem Group AG's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Alzchem Group AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alzchem Group AG (CHIX:ACTD) has a Equity-to-Asset of 0.42 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Alzchem Group AG and its competitors. This is 68% above median its historical median of 0.25. Over the past decade, Alzchem Group AG's Equity-to-Asset has ranged from 0.16 to 0.43. According to the industry distribution chart, Alzchem Group AG ranks #1229 out of 1612 companies in the Chemicals industry, placing it in the top 76.2%.
Is Alzchem Group AG's Equity-to-Asset too high?
Alzchem Group AG's current Equity-to-Asset of 0.42 is 68% above median its 10-year median of 0.25. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 0.43. The Chemicals industry median Equity-to-Asset is 0.60. Alzchem Group AG's value of 0.42 is 30% below this industry median. Based on the distribution chart, Alzchem Group AG ranks #1229 out of 1612 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Alzchem Group AG has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's Equity-to-Asset compare to LIN and SHW?
According to the Chemicals industry distribution chart, Alzchem Group AG ranks #1229 out of 1612 companies for Equity-to-Asset. This places Alzchem Group AG in the lower half of its industry. The industry median Equity-to-Asset is 0.60. Alzchem Group AG's value of 0.42 is 30% below this benchmark. Historically, Alzchem Group AG's own Equity-to-Asset has ranged from 0.16 to 0.43 over the past decade. While the company's 10-year median is 0.25 vs. the industry median of 0.60, Alzchem Group AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Chemicals company?
The median Equity-to-Asset among Chemicals companies is 0.60, based on 1,612 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alzchem Group AG's current Equity-to-Asset of 0.42 is 30% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Alzchem Group AG and its competitors. For the Chemicals industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alzchem Group AG's current Equity-to-Asset is 0.42, which is 68% above median its own 10-year median of 0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Alzchem Group AG (CHIX:ACTD) has a current Equity-to-Asset of 0.42. The current Equity-to-Asset is 0.42, which is 68% above median its 10-year median of 0.25 and 30% below the Chemicals industry median of 0.60. Alzchem Group AG's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Alzchem Group AG (CHIX:ACTD), the current Equity-to-Asset is 0.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
50GF Score
Get the complete analysis for CHIX:ACTD
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ACTD has been successfully added to your 
